The United States Patent and Trademark Office (USPTO) has extended the deadline for submitting comments on the state of patent eligibility jurisprudence, and its effect on investment and innovation in the United States, to October 15, 2021.
The comments will assist the USPTO in preparing a report to Congress in how current jurisprudence may impact U.S. investment and innovation, particularly in critical technologies like quantum computing, artificial intelligence, precision medicine, diagnostic methods, and pharmaceutical treatments. Continue Reading